In Vitro Fertilization Market is Set to Grow at a Rate of 9% CAGR During the Forecast Period of 2022 to 2032

From US$ 640 Million in 2021, the global in-vitro fertilization market is expected to reach US$ 1.6 Billion by 2032, with a Compound Annual Growth Rate (CAGR) of 9% predicted from 2022 to 2032.

Rising reprotourism and increasing incidences of male and female infertility are two key factors driving in vitro fertilization/IVF market growth. Infertility is a critical health problem that affects people from around the world.

Click on the link to get Sample of this Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-14305

Attributes Details
In Vitro Fertilization Market CAGR (2022 – 2032) 9%
In Vitro Fertilization Market (2026) US$ 990 Mn
In Vitro Fertilization Market Attraction Asia Pacific will remain attractive due to medical tourism

According to the American Pregnancy Association, male infertility accounts for 30% of infertility cases and leads to about one-fifth of infertility cases. The market will rise as people become more dependent on fertility treatments. The growing use of in vitro fertilization (IVF) techniques is being influenced by the availability of resources.

The emergence of the COVID-19 pandemic prompted the cessation of fertility treatments, which had a psychological impact on the women who had their treatments discontinued. Treatment clinics are now allowed to resume treatments under the condition that they observe stringent requirements.

Culture medium, capital equipment, and IVF disposable devices make up the in vitro fertilization instrument. In 2020, culture media dominated the in vitro fertilization/IVF market and accounted for a large portion of the income. The availability of money and an increase in research initiatives to improve the culture media were credited with in vitro fertilization/IVF market expansion.

The disposable devices market, on the other hand, is predicted to increase at the quickest rate over the projection years, as the in vitro fertilization/IVF market participants provide disposable devices such as needles, slides, and chambers to fulfil sterility and regulatory criteria.

The sector of fertility clinics led the global the in vitro fertilization/IVF market, accounting for the majority of revenue. Throughout the projected period, the category is expected to maintain its leading the in vitro fertilization/IVF market position while increasing at the highest rate.

The rise of fertility clinics is expected to be fuelled by factors such as cost-effectiveness, availability of experts, and little or no risk of Hospital-Acquired Infections (HAIs). IVF procedures are also carried out in hospitals.

In 2020, the frozen non-donor segment dominated the global in vitro fertilization/IVF market. However, in 2020, the fresh non-donor sector had the second-highest revenue in vitro fertilization/IVF. The significant proportion of this category is due to the higher success percentage on the first try.

Some of the in vitro fertilization/IVF market’s latest advancements include disposable slides for sperm counting, an imaging-based monitoring system to extract the best motile sperm, and the usage of disposable microchips.

During the projection period, Asia-Pacific is expected to be the fastest-growing in vitro fertilization/IVF market. The in vitro fertilization/IVF market is being driven by several causes, including rising ovulation disorders in women, rising trends in assisted reproduction technologies, and rising rates of infertility. In addition, government programmes for fertility therapy are projected to provide in vitro fertilization/IVF market development opportunities.

Key Takeaways:

  • In 2020, culture media dominated the in vitro fertilization/IVF market, accounting for more than 41% of total sales.
  • In 2020, Europe dominated the worldwide in vitro fertilization/IVF market with a revenue share of about 37%.
  • In 2020, the frozen non-donor category accounted for more than 47% of the total in vitro fertilization/IVF market sales.
  • In 2020, the fertility clinics sector led the global in vitro fertilization/IVF market, accounting for more than 79% of total revenue.

“Boost in productivity tourism, a rise in the number of fertility clinics, and the lower cost of IVF procedures in emerging countries compared to developed countries are expected to provide lucrative market expansion opportunities.”

Competitive landscape:

CooperSurgical, Inc., Vitrolife AB, Thermo Fisher Scientific Inc., Merck KGaA, and Fujifilm Holdings Corp. are some of the major competitors in the in vitro fertilization/IVF market. These in vitro fertilization/IVF market participants use a variety of marketing techniques to grow their in vitro fertilization/IVF market share, including mergers and acquisitions, product launches, and regional expansion.

  • Royal Philips and Merck KGaA announced a multi-year collaboration in January 2021 to explore digital solutions for individualized reproductive treatments.
  • Merck KGaA got European Commission (EC) Marketing Authorization (MA) in January 2020 for its novel GONAL-f (follitropin alfa) 150 IU pen, which is intended for patients from the start to the conclusion of their reproductive stimulation cycle and requires lesser dosages.
  • TMRW Life Sciences said in February 2021 that it had created the world’s first automated frozen specimen management system for IVF embryos and eggs. TMRW’s proprietary platform has been placed in a number of top reproductive clinics throughout the United States, ushering in a new era of integrated, software-enabled administration of the millions of eggs and embryos that are at the heart of modern IVF. The firm is expanding internationally, and it has announced that by the summer of 2021, it will be in UK-based reproductive clinics.

Click on the link to get the TOC of this Report: https://www.futuremarketinsights.com/reports/in-vitro-fertilization-market/table-of-content

About the Healthcare Division at Future Market Insights

Future Market Insights facilitates corporates, government, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success. Our unique approach to gathering market intelligence equips you in devising innovation-driven trajectories for your business. Know more about our sector coverage here

About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
​United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Leave a comment

Your email address will not be published. Required fields are marked *